7775 大研医器

累計 / 通期：4Q / 3Q / 2Q / 1Q

決算期	四半期	売上高	営業利益	営業利益率	経常利益	経常利益率	純利益	純利益率	EPS	売上高前年比	営業利益前年比	経常利益前年比	純利益前年比
2026/03	4Q	10,290	1,277	12.4%	1,274	12.4%	922	9.0%	32.12	3.4%	-15.5%	-15.6%	-16.0%
2025/03	4Q	9,951	1,512	15.2%	1,510	15.2%	1,097	11.0%	38.21	2.1%	4.9%	4.1%	11.0%
2024/03	4Q	9,750	1,442	14.8%	1,450	14.9%	988	10.1%	34.41	6.7%	36.8%	37.7%	38.8%
2023/03	4Q	9,137	1,054	11.5%	1,053	11.5%	712	7.8%	24.79	7.0%	-8.3%	-8.6%	-14.3%
2022/03	4Q	8,540	1,150	13.5%	1,152	13.5%	831	9.7%	28.93	8.6%	24.9%	20.4%	23.1%
2021/03	4Q	7,861	921	11.7%	957	12.2%	675	8.6%	23.50	-7.8%	-22.9%	-20.9%	-21.4%
2020/03	4Q	8,523	1,194	14.0%	1,210	14.2%	859	10.1%	29.92	1.4%	-4.4%	-2.8%	0.9%
2019/03	4Q	8,406	1,249	14.9%	1,245	14.8%	851	10.1%	29.05	-	-	-	-

決算期	四半期	売上高	営業利益	営業利益率	経常利益	経常利益率	純利益	純利益率	EPS	売上高前年比	営業利益前年比	経常利益前年比	純利益前年比
2026/03	4Q	10,290	1,277	12.4%	1,274	12.4%	922	9.0%	32.12	3.4%	-15.5%	-15.6%	-16.0%
2025/03	4Q	9,951	1,512	15.2%	1,510	15.2%	1,097	11.0%	38.21	2.1%	4.9%	4.1%	11.0%
2024/03	4Q	9,750	1,442	14.8%	1,450	14.9%	988	10.1%	34.41	6.7%	36.8%	37.7%	38.8%
2023/03	4Q	9,137	1,054	11.5%	1,053	11.5%	712	7.8%	24.79	7.0%	-8.3%	-8.6%	-14.3%
2022/03	4Q	8,540	1,150	13.5%	1,152	13.5%	831	9.7%	28.93	8.6%	24.9%	20.4%	23.1%
2021/03	4Q	7,861	921	11.7%	957	12.2%	675	8.6%	23.50	-7.8%	-22.9%	-20.9%	-21.4%
2020/03	4Q	8,523	1,194	14.0%	1,210	14.2%	859	10.1%	29.92	1.4%	-4.4%	-2.8%	0.9%
2019/03	4Q	8,406	1,249	14.9%	1,245	14.8%	851	10.1%	29.05	-	-	-	-